Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Allison Noe"'
Autor:
Hetty E. Carraway, Cassandra M Kerr, Hassan Awada, Allison Noe, Yuriy Fedorov, Steffan T. Nawrocki, Daniel J. Lindner, Heesun J. Rogers, Bartlomiej P Przychodzen, Anjali S. Advani, Yvonne Parker, Kevin R. Kelly, James G. Phillips, Vera Adema, Rachel Toth, Valeria Visconte, Drew J. Adams, Anand D. Tiwari, Jennifer S. Carew, Mikkael A. Sekeres, Christina Snider, Jaroslaw P. Maciejewski
Publikováno v:
Blood. 134:564-564
SF3B1 mutations disrupt normal pre-mRNA splicing to cause disease. Drugs inhibiting the interaction between the SF3b complex and RNA or agents degrading auxiliary splicing factors are being tested as new avenues for targeted therapy in myeloid neopla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f64c075751b225756abda29cc7a7f6f5
https://doi.org/10.1182/blood-2019-129189
https://doi.org/10.1182/blood-2019-129189
Autor:
Hetty E. Carraway, Allison Noe, Vera Adema, Drew J. Adams, Bartlomiej P Przychodzen, Yvonne Parker, Daniel J. Lindner, Steffan T. Nawrocki, Tomas Radivoyevitch, Kevin R. Kelly, Mikkael A. Sekeres, Yuriy Fedorov, Richard A. Padgett, Hassan Awada, Cassandra M. Hirsch, Rachel Toth, Jaroslaw P. Maciejewski, Valeria Visconte, James G. Phillips, Heesun J. Rogers, Amy C Graham, Anjali S. Advani, Christina Snider, Jennifer S. Carew
Publikováno v:
Blood. 132:211-211
SF3B1 is a splicing factor gene whose mutations are pathognomonic of MDS with ring sideroblasts. Because of the ubiquitous importance of splicing, a major barrier in targeting cells with spliceosomal mutations is the discovery of agents decreasing th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c042059f42b2ee50709b37e7834f9ae
https://doi.org/10.1182/blood-2018-99-116411
https://doi.org/10.1182/blood-2018-99-116411